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The bovine papillomavirus E2 transactivator protein is a multifunctional protein that activates viral transcription, cooper-
ates in initiation of viral DNA replication, and is required for long-term episomal maintenance of viral genomes. We have
shown previously that the E2 transactivator protein and bovine papillomavirus type 1 genomes are associated with mitotic
chromosomes and have proposed that E2 links the genomes to cellular chromosomes to ensure segregation to daughter
nuclei. In this study, we show that E2 is associated with cellular chromosomes at all stages of mitosis. We also further map
the regions of E2 that are required for this association. The transactivation domain of E2 is necessary and sufficient to
mediate the interaction with mitotic chromosomes; the DNA binding domain, and the flexible hinge region that separates the
two domains, is not required. Furthermore, mutation of previously identified phosphorylation sites (serine residues 235, 298,
and 301) has no effect on the ability of the E2 protein to bind mitotic chromosomes. © 2000 Academic PressINTRODUCTION
Faithful partitioning of genetic material in cell division
is essential for continued viability of all organisms. In
eukaryotes, mitotic chromosomes are segregated to the
daughter cells by attachment of their kinetochores to the
spindle structure. The kinetochores of duplicated chro-
mosomes are linked and move to the opposite poles of
the spindle via microtubules, resulting in the delivery of
one copy of each chromosome to the daughter cells. In
prokaryotes, the mechanism of genome segregation is
less well understood. No well-defined spindle or other
structure has been identified that is responsible for di-
recting the bacterial chromosome to the daughter cells.
However, it has been shown that partitioning of low-copy
number prokaryotic plasmids is mediated by the interac-
tion of two plasmid-encoded partitioning proteins with a
cis-acting centromere site. The newly replicated plas-
mids pair at mid-cell followed by separation and active
movement to the poles of the predivisional cell by some
unknown mechanism (Jensen and Gerdes, 1999).
DNA viruses that possess episomal genomes, such as
papillomavirus or Epstein–Barr virus (EBV), must also
maintain their genomes as stable extrachromosomal el-
ements in the nuclei of infected cells. To ensure that viral
genomes are maintained for generation after generation,
the virus must have an efficient partitioning mechanism.
We, and others, have previously reported that the E2
transactivator protein and bovine papillomavirus type-1
(BPV-1) genomes are linked to mitotic chromosomes in
dividing cells (Skiadopoulos and McBride, 1998; Lehman
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124and Botchan, 1998). We proposed a model in which
E2-bound viral genomes are transiently associated with
cellular chromosomes during mitosis to ensure that viral
genomes are segregated to daughter cells in approxi-
mately equal numbers. Ilves et al. (1999) further con-
firmed that the E2 protein is required for the association
of plasmids containing E2 DNA binding sites with mitotic
chromosomes.
The E2 open reading frame (ORF) of BPV-1 encodes
three different proteins. The full-length protein (E2-TA) is
the transcriptional transactivator of the virus, and two
smaller proteins, E2-TR and E8/E2, act as transcriptional
repressors (Spalholz et al., 1985; Lambert et al., 1987;
Choe et al., 1989). The E2-TA protein is also required for
viral DNA replication (Ustav and Stenlund, 1991). To ini-
tiate DNA replication, E2 binds cooperatively to the origin
with the E1 protein (Mohr et al., 1990; Blitz and Laimins,
1991, Wilson and Ludes-Meyers, 1991) Plasmids contain-
ing the minimal replication origin can replicate tran-
siently in cells expressing the E1 and E2 proteins, but
replicated DNA is lost with time. Long-term, stable main-
tenance of such plasmids requires, in addition, the
minichromosome maintenance element, a cis element
containing multiple E2 binding sites (Piirsoo et al., 1996).
This correlates very well with the observation that E2-TA
and viral genomes are linked to cellular mitotic chromo-
somes, which correlates with the ability of the plasmids
to be episomally maintained (Ilves et al., 1999). This
association also ensures that the viral genomes are
enclosed in the nuclear envelope as it reforms in telo-
phase.
Mitotic chromosomes are surrounded by a perichro-
mosomal region that appears to consist of filaments and
granules when visualized by electron microscopy (re-
viewed in Hernandez-Verdun and Gautier, 1994). Many
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125PAPILLOMAVIRUS E2 PROTEIN/CHROMOSOME INTERACTIONnuclear proteins, such as those from the nucleolus and
nuclear envelope, migrate to this region of the chromo-
some at mitosis to ensure that they will be correctly
distributed to the nuclei of the daughter cells. Some of
these passenger proteins interact with the chromo-
somes throughout mitosis and others disassociate be-
fore the nuclear membrane protein reforms in telophase.
In this study, we further analyzed the stages of mitosis at
which the E2-TA is found associated with cellular chro-
mosomes.
The E2 transactivator consists of two conserved do-
mains linked by a flexible hinge region (reviewed in
McBride and Myers, 1997). The C-terminal region is re-
quired for DNA binding and dimerization, and the N-
terminal domain is specifically required for the transac-
tivation and replication functions of E2. We have previ-
ously shown that the shorter E2 repressor proteins,
which do not contain the transactivation domain, cannot
associate with mitotic chromosomes and that deletions
in the transactivation domain abrogate the interaction
(Skiadopoulos and McBride, 1998). Genetic analysis of a
BPV-1 genome with mutations in the E2 phosphorylation
sites led Lehman and Botchan (1998) to predict that
segregation of BPV-1 genomes depends on tethering to
chromosomes, which is regulated by E2 phosphoryla-
tion. They find that in cells containing this mutated viral
genome, the E2-TA protein is not associated with mitotic
chromosomes and the viral genomes have a segregation
defect. In this study, we analyzed the role of the E2-TA
phosphorylation sites on direct chromosomal attachment
of E2 in the absence of the viral genome and other viral
gene products and found that modification of the specific
phosphorylation sites of the hinge region of E2-TA is not
required. To gain more insight into the mechanism of
papillomavirus genome segregation, we further deter-
mined which regions of the E2 protein are required and
sufficient for interaction with mitotic chromosomes.
RESULTS
E2 expression systems
To further characterize the interaction of E2 with the
mitotic chromosomes, the localization of E2 proteins was
analyzed in CV-1 cells infected with recombinant SV40
viruses that encode a series of truncated E2-TA proteins
or in stable lines expressing different regions of the
E2-TA protein. The SV40-BPV recombinant viruses were
first developed by Settleman and DiMaio (1988) and
consist of an SV40 viral genome with the early region
replaced with the E2-E5 region of BPV-1. These PAVA
viruses express the E2 protein and replicate and are
packaged in cells expressing SV40 large T antigen.
Packaged recombinant virus can be used to efficiently
infect the CV-1 cells used in this study. Alternatively, E2
localization was analyzed in stable CV-1 cell lines con-
taining EBV-derived episomal vectors that expressed E2
from an inducible metallothionein promoter. In BPV-1transformed cells and in the basal cells of a papilloma,
the E2 proteins are expressed at very low levels (Hubbert
et al., 1988, Penrose and McBride, manuscript submit-
ted). Analysis of E2 chromosomal association could only
be carried out in cells expressing low to moderate
amounts of E2; overexpression resulted in E2 that was
prone to aggregate in the cytoplasm and was unable to
associate with chromosomes. The two E2 expression
systems described in this study produced moderate lev-
els of E2 protein that were correctly localized to the
nucleus and to mitotic chromosomes.
E2-TA remains associated with mitotic chromosomes
throughout mitosis
Previous studies have documented the interaction of
the E2-TA protein with mitotic chromosomes (Skiadopou-
los and McBride, 1998; Lehman and Botchan, 1998; Ilves
et al., 1999). Many cellular proteins translocate to cellular
chromosomes during mitosis to ensure that they are
segregated to the nuclei of daughter cells. However, the
stage of mitosis at which they associate and disassoci-
ate can vary, and many disassociate before the nuclear
membrane reforms in telophase. To further analyze the
temporal association of E2 with mitotic chromosomes,
E2-specific immunofluorescence was carried out in a
CV-1 cell line that stably expressed E2-TA from an induc-
ible metallothionein promoter. To identify mitotic cells,
the cellular DNA was labeled with Hoechst, a fluorescent
dye that interchelates in DNA. Cells were also stained
with an antibody directed against phosphorylated H3
histone (H3-P). H3 is phosphorylated throughout mitosis,
and this modification correlates with chromatin conden-
sation (Goto et al., 1999; Hendzel et al., 1997). Phosphor-
ylation of H3 initiates late in the G2 phase of the cell
ycle; it begins in pericentromeric heterochromatin and
xtends throughout the condensing chromosomes as
ells progress further into mitosis (Hendzel et al., 1997;
ei et al., 1999). Dephosphorylation of H3 begins in
naphase and is complete at telophase, just before chro-
atin decondensation (Hendzel et al., 1997). The H3
arker allowed us to more precisely define the stage at
hich E2 associated with the chromosomes. Examples
f cells at all stages of mitosis are shown in Fig. 1. H3
hosphorylation was initiated in late G2 cells (no DNA
condensation was yet visible with Hoechst staining) in
regions of DNA described previously as pericentromeric
heterochromatin (Hendzel et al., 1997). Within these
cells, the E2 staining occurs throughout the nucleus and
colocalizes with the bulk of uncondensed chromatin and
does not colocalize with H3-P. As the cells proceed to
enter prophase (condensed DNA is visible), both E2 and
phosphorylated histone H3 proteins are found to asso-
ciate with condensed chromosomes. E2 remains asso-
ciated with mitotic chromosomes at every stage of mito-
sis. In contrast to H3-P, E2 is still associated with con-
densed chromosomes in telophase and always
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126 BASTIEN AND MCBRIDEcolocalizes with cellular DNA. The chromosomal associ-
ation of E2 throughout mitosis most likely reflects its role
in segregating viral genomes. Dissociation of the ge-
nomes before the nuclear envelope formed in telophase
would be counterproductive, and many genomes could
be lost in the cytoplasm. On the contrary, proteins that
are required to reassemble the nucleus (such as nucle-
olar or nuclear membrane-derived proteins) must be
released at an earlier stage.
E2 phosphorylation is not required for the association
with mitotic chromosomes
The hinge region of E2 contains two major phosphor-
ylation sites at position 298 and 301 and a minor one at
position 235 (McBride et al., 1989a; Lehman et al., 1997).
Serine residue 290 is not an actual phosphorylation site,
but a mutation in this residue is present in phosphory-
lation defective E2 proteins that were analyzed previ-
ously (A3, A4, and AAA; McBride et al., 1989a; Lehman
and Botchan, 1998), and so it was analyzed in this study.
Lehman and Botchan (1998) reported that in cells con-
taining BPV-1 viral mutations that prevent E2 phosphor-
ylation, E2 proteins are excluded from the chromosomes.
To further investigate the role of E2 phosphorylation in
the interaction with mitotic chromosomes, E2-TA proteins
containing point mutations at the four serine residues
described earlier were expressed in CV-1 cells from
recombinant PAVA viruses. As shown in Fig. 2, E2-TA
proteins containing a single serine-to-alanine point sub-
stitution at each of the three phosphorylation sites are
closely associated with mitotic chromosomes. Similar
results were obtained for the E2-TA proteins containing
an alanine at position 290. E2-TA proteins containing
point mutations at either both major phosphorylation
FIG. 1. Subcellular localization of E2 and phosphorylated histone H3
pMEP-E2 cells throughout the cell cycle was analyzed with a confocal
are depicted: The first set of panels shows CV-1 pMEP cells that do no
and anti-E2 (red) stainings are shown at the bottom. Hoechst-stainedsites (298, 301) as well as at all three phosphorylation msites (235, 298, 301) remain associated with mitotic chro-
mosomes. Therefore, phosphorylation at these sites is
not directly required for the association of E2 with mitotic
chromatin.
The hinge of E2 is not required for the association
with the mitotic chromosomes
Initial characterization of the regions of E2-TA required
for association with mitotic chromosomes showed that
the two repressor forms of E2, E2-TR and E8/E2, did not
associate with mitotic chromosomes (Skiadopoulos and
McBride, 1998). Furthermore, deletions in the N-terminal
transactivation domain abrogated the interaction. The
internal hinge region of E2 is thought to form a flexible
link between the DNA binding domain and the transac-
tivation domain. The length and the amino acid compo-
sition of the hinge region vary among papillomaviruses,
and it is not required for the transactivation function
(McBride et al., 1989b). However, a small spacer region
is required between the domains for the replication ini-
tiation function of E2 (Winokur and McBride, 1992). To
determine whether the hinge portion of E2 is required for
the association with mitotic chromosomes, the localiza-
tion of E2-TA proteins containing in-frame deletions of
the hinge region (E2D220-283, E2D285-309, E2D220-309) was ana-
lyzed in CV-1 cells infected with recombinant SV40 virus
expressing the different proteins. E2 proteins containing
internal in-frame deletion that removed part of the hinge
(E2D220-283, E2D285-309) are able to induce DNA replication
and activate transcription. However, E2 proteins with
deletions of the entire hinge region (E2D220-309) are able to
ctivate transcription and enhance E1 specific-origin
inding yet are unable to support DNA replication (Wino-
ur and McBride, 1996, 1992). As shown in Fig. 3, in
g the cell cycle. Immunofluorescent detection of E2 and H3-P in CV-1
canning microscope. Representative cells from each stage of mitosis
s E2. Anti-H3-P staining (green) is shown in the middle set of images,
ages (blue) are shown along the top.durin
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127PAPILLOMAVIRUS E2 PROTEIN/CHROMOSOME INTERACTIONPAVAkzE2-TAD220-309, or PAVAkzE2-TAD285-309, the E2-TA pro-
teins are observed as a random speckled pattern asso-
ciated with the chromosomes that is indistinguishable
from that of wild-type E2. Therefore, the hinge of E2 is not
required for association with mitotic chromosomes.
The DNA binding domain of E2 is not required for the
interaction with mitotic chromosome
We have previously shown that an E2-TA protein con-
taining a point mutation (arginine to lysine at position
344) that rendered it defective in DNA binding is able to
associate with mitotic chromosomes, showing that the
interaction is not mediated by binding to cellular DNA
sequences (Skiadopoulos and McBride, 1998). However,
the DNA binding domain of E2 might still be required for
interaction via another mechanism, such as interaction
with other chromosomal proteins. We made several un-
successful attempts to express the transactivation do-
main of E2 from recombinant SV40 virus but were never
able to detect the protein by immunofluorescence. In
retrospect, this was probably due to masking of the B201
antibody epitope in this protein under the conditions
used for immunofluorescence. Therefore, to further ex-
amine the requirement for the DNA binding domain of
E2, we generated PAVA viruses expressing E2 fusion
proteins in which the E2 DNA binding domain was re-
placed by the Gal4 DNA binding domain. The yeast Gal4
protein is a well-characterized transcriptional transacti-
vator that has no intrinsic replication properties in other
viral systems (Bennet-Cook and Hassel, 1991; Gou and
DePamphilis, 1992), and like the E2 protein, it forms
dimers through the DNA binding domain. The first 147
amino acids of the GAL4 protein constitute the DNA
binding and dimerization domain (Keegan et al., 1986;
Carey et al., 1989). Three recombinant PAVA viruses were
FIG. 2. E2 proteins were detected in CV-1 cells infected with recombin
Panels a and b show uninfected CV-1 cells; panels c and d, CV-1 cells
290; panels g and h, infected with pPAVAkzE2-TA A298; panels i and j,
290, 298, 301; and panels m and n, infected with pPAVAkzE2-TA A235, 290, 298, 301.
to identify cells undergoing mitosis. Panels b, d, f, h, j, l, and n show Fgenerated that expressed E2-Gal4 fusion proteins thatcontained the N-terminal domain of E2 and different
lengths of the hinge region fused in-frame to the Gal4
DNA binding domain (E21-219Gal41-147, E21-250Gal41-147, and
21-283Gal41-147). These three fusion proteins are function-
ally active in that they are able to activate transcription
from a Gal4-responsive plasmid and can enhance bind-
ing of E1 to a BPV-1 chimeric origin containing Gal4
binding sites in place of the E2 binding sites (Winokur
and McBride, 1996). As shown in Fig. 4, all three E2-Gal4
fusion proteins were associated with mitotic chromo-
somes in CV-1-infected cells. Therefore, the specific E2
DNA binding domain is not required for the association
with mitotic chromosomes. These results also confirm
that the hinge region of E2 is unnecessary.
The transactivation domain of E2 is sufficient for the
association with mitotic chromosomes
The E2-TR and E8/E2 repressors proteins do not as-
sociate with mitotic chromosomes, and a deletion in the
transactivation domain abrogates this interaction, show-
ing that the transactivation domain is required for this
interaction(Skiadopoulos and McBride, 1998). However,
these findings did not prove that the transactivation do-
main is sufficient for the interaction, because a DNA
binding domain was always present. To determine
whether the transactivation domain alone is sufficient to
mediate the association with mitotic chromosomes, it
was expressed in the absence of any other domain.
Difficulties were encountered in detecting the E2 trans-
activation domain when expressed alone from recombi-
nant PAVA viruses (see earlier). Consequently, we devel-
oped a CV-1 cell line expressing either wild-type E2 or
the E2 transactivation domain (E21-218) fused to an SV40
nuclear localization signal and an HA (influenza hemag-
A viruses by immunofluorescence using the B201 E2 specific antibody.
ed with pPAVAkzE2-TA A235; panels e and f, infected with pPAVAkzE2-TA
d with pPAVAkzE2-TA A301; panels k and l, infected with pPAVAkzE2-TA
ls a, c, e, g, i, k, and m, cellular DNA was stained with propidium iodide
beled E2 protein in the same field of cells.ant PAV
infect
infecte
In paneglutinin) epitope. The localization of E2 protein in mitotic
128 BASTIEN AND MCBRIDEcells from these lines was determined by immunofluo-
rescence. As shown in Fig. 5, the chimeric E2 protein
FIG. 3. E2 proteins were detected in CV-1 cells infected with recom-
binant PAVA viruses by immunofluorescence using the B201 E2 specific
antibody. Panels a and b show uninfected CV-1 cells; panels c and d,
cells infected with pPAVAkzE2-TAD220-283; panels e and f, infected with
pPAVAkzE2-TAD285-309; and panels g and h, infected with
pPAVAkzE2-TAD220-309. In panels a, c, e, and g, cellular DNA was stained
with propidium iodide to identify cells undergoing mitosis. Panels b, d,
f, and h show FITC-labeled E2 protein in the same field of cells.was found to be associated with mitotic chromosomes.Therefore, the transactivation domain is sufficient for the
association with mitotic chromosomes.
DISCUSSION
We previously determined that the BPV-1 viral ge-
nomes and the E2-TA protein are associated with mitotic
chromosomes (Skiadopoulos and McBride, 1998). In this
study, we further characterized the regions of the E2
protein that are required for the direct association of the
E2 protein with condensed chromosomes in the absence
of viral genomes or other viral gene products. To do this,
it was necessary to express the E2 proteins at moderate
levels. When E2 was expressed at very high levels, from
either transfected expression plasmids or by infection of
COS-7 cells with PAVA viruses, E2 was very prone to
localize in the cytoplasm and was not associated with
mitotic chromosomes. We believe that under these cir-
cumstances, E2 was misfolded and aggregated. In this
study, two different E2 expression systems were found to
be useful: Small quantities of DNA could be delivered
directly to the nucleus of CV-1 cells from recombinant
PAVA viruses from which E2 was expressed from the
relatively weak SV40 early promoter. Alternatively, stable
CV-1 cell lines were established that contained EBV-
based episomally replicating vectors that expressed E2
from an inducible metallothionein promoter (Penrose and
McBride, manuscript submitted). The level of E2 expres-
sion could be regulated by the concentration of heavy
metals in the medium, and at low to moderate levels of
E2 protein, chromosomal association was observed.
We had shown previously that the DNA binding func-
tion of E2 is not necessary, and here we show that the
DNA binding domain itself is not required for the asso-
ciation with mitotic chromosomes. Therefore, the inter-
action of E2 with mitotic chromosomes cannot be medi-
ated by binding to cellular DNA. However, it is predicted
that the E2 DNA binding domain is required to mediate
the link between the E2 binding sites on the viral ge-
nomes and the cellular chromosomes. Furthermore, the
flexible hinge region that separates the transactivation
and DNA binding domains is not required for chromo-
somal interaction. An E2 protein with all of the hinge
sequences removed (E2D220-309) is able to activate tran-
scription and enhance E1 specific-origin binding yet is
unable to support DNA replication (Winokur and
McBride, 1996, 1992). However, this protein efficiently
associates with mitotic chromosomes, indicating that
this is not the reason for its inability to support DNA
replication. We also show that the transactivation domain
of E2 protein is necessary and sufficient for the associ-
ation with the mitotic chromosomes. This data are sum-
marized in Fig. 6. The E2 transactivation domain is a
multifunctional domain and is required to interact with
several cellular factors (AMF-1, SP1, TFIIB) as well as the
viral E1 and L2 proteins (Breiding et al., 1997; Li et al.,
1991; Yao et al., 1998; Benson et al., 1997; Mohr et al.,
129PAPILLOMAVIRUS E2 PROTEIN/CHROMOSOME INTERACTIONFIG. 4. E2 proteins were detected in CV-1 cells infected with recombinant PAVA viruses by immunofluorescence using the B201 E2 specific antibody.
Panels a and b show CV-1 cells infected with pPAVAkzGal41-147; panels c and d, infected with pPAVAkzE21-219Gal41-147; panels e and f, infected with
pPAVAkzE21-250Gal41-147; and panels g and h, infected with pPAVAkzE21-283Gal41-147. In panels a, c, e, and g, cellular DNA was stained with propidium iodide
to identify cells undergoing mitosis. Panels b, d, f, and h show FITC-labeled E2 protein in the same field of cells.
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130 BASTIEN AND MCBRIDEFIG. 5. E2 proteins were detected in CV-1 pMEP (a, b, c, f), pMEP-E2 (g, h); and pMEP-E21-218 HA cells (c, d) using either the B201 E2-specific antibody
r the anti-HA epitope antibody, as indicated. In panels a, c, e, and g, cellular DNA was stained with propidium iodide to identify cells undergoing
itosis. Panels b, d, f, and h show FITC-labeled E2 protein in the same field of cells.
131PAPILLOMAVIRUS E2 PROTEIN/CHROMOSOME INTERACTION1990; Day et al., 1998). This domain appears to have a
very precise structure that is easily disrupted by deletion
or point mutation. A partial structure of the HPV18 E2
transactivation domain has been solved, and it appears
to have a cashew-shaped form with a glutamine-rich
a-helix packed against a b-sheet framework. The deter-
minants for replication and transcription show extensive
overlap (Harris and Botchan, 1999). Additionally, we have
found that E2 proteins with conserved point mutations
that inactivate the transactivation function of the E2 N-
terminal domain are unable to associate with mitotic
chromosomes (Zheng and McBride, unpublished obser-
vations). Further studies are required to isolate the cel-
lular protein or proteins that are responsible for the
interaction of E2 with mitotic chromosomes.
E2 phosphorylation has been implicated in copy num-
ber control, as well as long-term maintenance of BPV-1
viral episomes (McBride et al., 1989a; Lehman et al.,
1997). E2 proteins containing a serine-to-alanine muta-
tion at position 301 (A301 E2) leads to a 10- to 20-fold
increase in viral DNA copy number (McBride and How-
ley, 1991). Lehman and Botchan have demonstrated that
viral genomes with mutations that prevent phosphoryla-
tion of the hinge region of E2 are defective for transfor-
mation and that cells containing such mutants are un-
able to maintain the viral genomes as episomes. Further-
more, they found that BPV-1 viral genomes and E2
protein in these cells are not associated with mitotic
FIG. 6. Diagram of the regions of E2-TA required for interaction with
shown, as well as their ability to bind mitotic chromosomes. The E2 tran
The N-terminal domain of E2 includes approximately the first 200 amin
The C-terminal 85 amino acids are required for DNA binding and dimer
analyzed in this study are indicated. The boxes at the C terminus of E2
epitope from influenza virus.chromosomes, and they proposed that E2 phosphoryla-tion regulates the association of E2 with mitotic chromo-
somes. Recently, we have shown that E2 proteins with a
serine-to-alanine mutation in the phosphorylation site at
position 301 show greatly reduced ubiquitination and
degradation by the proteasome, leading to a substantial
increase in half-life compared with wild-type E2 (Penrose
and McBride, manuscript submitted). These findings
suggest that E2 phosphorylation regulates E2 protein
levels, which could in turn determine the viral genome
copy number by modulating the quantity of viral ge-
nomes that are bound to chromosomes and segregated
to daughter cells. However, we also find that E2 is sus-
ceptible to aggregation when overexpressed. The E2
proteins play a pivotal role in viral transcription and DNA
replication, and changes in E2 levels and properties
could have pleiotropic effects on many viral functions.
This could explain why Lehman and Botchan observed
defective segregation and E2 chromosomal association
with these mutants in the background of the entire BPV-1
genome. Lehman and Botchan also found that these
defects can be rescued by second site mutations in the
E1 protein, indicating that the phosphorylation mutants
have a complex phenotype in the background of the
entire viral genome. In this study, we show that E2
proteins containing identical mutations in the phosphor-
ylation sites are able to bind mitotic chromosomes as
efficiently as wild-type E2 proteins. Therefore, in the
absence of the viral genome and any other viral proteins,
c chromosomes. The structures of the proteins used in this study are
tor consists of two conserved domains linked by a flexible hinge region.
and is required for the transactivation and replication functions of E2.
. The position of the four serine residues in the hinge region that were
HA represent the nuclear localization signal of SV40 virus and the HAmitoti
sactiva
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132 BASTIEN AND MCBRIDEmodulate the interaction of the E2 protein with mitotic
chromosomes.
Mitosis is characterized by inhibition of transcription,
condensation of cellular chromosomes, and redistribu-
tion of nuclear proteins. The mitotic chromosomal pe-
riphery is composed of nonhistone proteins that are
associated with the chromosomal surface during mitosis
(reviewed in Hernandez-Verdun and Gautier, 1994). Many
cellular “passenger proteins,” such as those derived from
the nuclear matrix, the nuclear membrane, and the nu-
cleolus, migrate to the periphery of condensed mitotic
chromosomes to ensure that they are equally divided to
the nuclei of the daughter cells. These proteins are
observed to associate and disassociate with the cellular
chromosomes at different times of mitosis depending on
their function within the cell.
Many chromosomal proteins associate temporally
with chromosomes at specific stages of the cell cycle.
For example, most transcription factors are dissociated
from chromatin during mitosis (Martinez-Balbas et al.,
1995). The high mobility group 14/17 (HMG-14/-17) pro-
teins form specific complexes with nucleosomes. How-
ever, during mitosis, these proteins are transiently dis-
sociated from chromatin (Hock et al., 1998). They colo-
alize with nuclear DNA in interphase and prophase but
issociate in metaphase and anaphase. They must be
eimported into the newly formed nucleus and colocalize
gain with the DNA in late telophase.
Another class of chromosomal proteins associates
emporally with chromosomes at specific stages of mi-
osis (usually metaphase and anaphase). Members of
his group include many nuclear matrix and nucleolar
roteins. Certain nucleolar proteins, such a fibrillarin,
eave the nucleoli as they are disintegrating at the G2/M
transition and form a network around the condensing
chromosomes (Fomproix et al., 1998). At telophase, they
move to regions of decondensing chromosomes where
nucleoli are being reformed. The HIV-1 Rev protein lo-
calizes predominantly to the nucleolus of HIV-1-infected
cells and behaves like a cellular nucleolar protein
through mitosis until telophase. Rev begins to accumu-
late at chromosomal periphery in late prophase and
remains associated until anaphase, when it begins to
appear in numerous nucleoli-derived foci. However,
when the nuclear envelope starts to reform, Rev is ex-
cluded from nuclei, and reentry is delayed until early G1
phase (Dundr et al., 1996, 1997).
Certain chromosomal proteins are similar to E2 in that
they are associated with mitotic chromosomes through-
out mitosis. Although most transcription factors are dis-
sociated from chromatin at mitosis, some, such as the
serum response factor p67SRF, remain associated and
re thought to be required to activate genes immediately
fter mitosis (Gauthier-Rouviere et al., 1991,). Topoisom-
rase II and the cell proliferation-associated antigen
i-67 are other examples of proteins that remain com-
lexed to chromosomes throughout mitosis (Mo and Aeck, 1999; Verheijen et al., 1989). One role of E2 is to
egregate viral genomes between the daughter cells and
o retain them in the nucleus after cell division. To fulfill
his function, the genomes must be associated with the
ondensed chromosomes early in mitosis and remain
ound until after the nuclear envelope has been re-
ormed. In this study, we examined the localization of E2
t each stage of mitosis and observed that, as predicted,
2 was associated with condensed chromosomes in
rophase and remained visibly bound until late telo-
hase, when the chromosomes were uncondensed. The
omponent of mitotic chromosomes important for the
ssociation of E2 proteins is still unknown, but proteins
ssociated with the chromosomal periphery would be
ood candidates.
It is now becoming apparent that many episomally
eplicating viruses link their genomes to mitotic chromo-
omes via a virally encoded protein. The EBNA1 protein
f Epstein–Barr virus (Grogan et al., 1983; Harris et al.,
985), the immediate-early protein (IE1) of CMV
Lafemina et al., 1989), and the latency-associated nu-
lear antigen (LANA) of human herpesvirus-8 (Ballestas
t al., 1999) can all associate with mitotic chromosomes.
here does not seem to be any common “chromosomal
ssociation” motif in the primary sequence of these pro-
eins, and it will be interesting to determine whether they
ssociate with a common cellular factor on mitotic chro-
osomes.
MATERIALS AND METHODS
ell culture
CV-1 and CMT4 (Gerard and Gluzman, 1985) cell lines
ere cultured in Dulbecco’s minimal essential media
upplemented with 10% fetal calf serum. Recombinant
V40 PAVA E2 viruses were produced in CMT4 cells, as
escribed previously (Settleman and DiMaio, 1988). CV-1
ells expressing the E2 proteins from a metallothionein
romoter were generated by transfection of CV-1 cells
ith pMEP-4 plasmids. Hygromycin B-resistant cells
ere selected, pooled, and screened for expression of
2 proteins by immunofluorescence.
lasmids and viruses
A series of E2 mutations were generated in the back-
round of a plasmid that could only express the full-
ength E2-TA protein; the E2-TR initiating methionine
amino acids 162 of E2-TA) in the pTZkzE2-TA constructs
had been changed to an isoleucine by mutating nucleo-
tide 3093 from ATG to ATC (Skiadopoulos and McBride,
1996). The DraII–BstXI E2 subfragments were subcloned
from pTZE2D220-283, pTZE2D220-309, pTZE2D285-309, pTZE2 A290,
pTZE2 A298, pTZE2 A301, pTZE2 A290, 298, 301, pTZE2 A235, 290, 298, 301
into pTZkz E2-TA, generating pTZkzE2-TAD220-283, pTZkzE2-
TAD220-309, pTZkzE2-TAD285-309, pTZkzE2-TA A290, pTZkzE2-TA298, pTZkzE2-TA A301, pTZkzE2-TA A290, 298, 301, and
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133PAPILLOMAVIRUS E2 PROTEIN/CHROMOSOME INTERACTIONpTZkzE2-TA A235, 290, 298, 301. BstEII–BstXI fragments contain-
ng the entire E2 ORF were subcloned from these
ZkzE2-TA plasmids into pPAVAkzE2-TA (Skiadopoulos and
McBride, 1996) to generate pPAVAkzE2-TAD220-283, pPAVAkzE2-
TAD220-309, pPAVAkzE2-TAD285-309, pPAVAkzE2-TA A290, pPA-
AkzE2-TA A298, pPAVAkzE2-TA A301, pPAVAkzE2-TA A290, 298301,
and pPAVAkzE2-TA A235, 290, 298, 301. pTZkzE2-TA A235 was gen-
erated by subcloning an E2 DraII–BstXI fragment from
C59 into pTZkzE2-TA. C59 is a cDNA cloned from a bovine
wart library (Yang et al., 1985). The E2 expressed from
this cDNA has a serine-to-alanine mutation at position
235; it is not clear whether this is a mutation generated
during cloning or a natural variant of BPV-1. The BstEII–
BstXI E2 fragment was subcloned from pTZkzE2-TA A235
into pPAVAkzE2-TA to generate pPAVAkzE2-TA A235. A se-
ies of C59-based plasmids expressing chimeric proteins
ontaining the E2 transactivation domain and portions
f the hinge region linked in-frame to the Gal4 DNA
inding domain have been described previously (Wino-
ur and McBride, 1996). A BstEII–BstXI fragment was
ubcloned from these plasmids into pPAVAkzE2-TA
to generate pPAVAkzE2-TA1-219Gal41-147, pPAVAkzE2-TA1-250
Gal41-147, pPAVAkzE2-TA1–283Gal41-147, and pPAVA-Gal41-147. A
lasmid that expresses the N-terminal domain of E2
inked to the SV40 nuclear localization signal (PKKKRKV)
nd the influenza HA epitope (residue 98–106 of the HA
rotein: YPYDVPDYA) was generated by inserting dou-
le-stranded oligonucleotides that encoded these sig-
als (AM520: GCTAGCTACCCATACGACGTCCCAGAC-
ACGCTTGAG and AM521 GATCCTCAAGCGTAGTCT-
GGACGTCGTATGGGTA) at the DraII site of pTZkzE2 to
enerate pTZkzE21-218HA. An EBV-based episomal vector
that expresses E2 from an inducible metallothionein pro-
moter was generated by cloning the HindIII–BamHI frag-
ment of pTZkzE21-218 HA into pMEP-4 (InVitrogen, San
Diego, CA) generating pMEP-E21-218HA. pMEP-E2, ex-
pressing the full-length E2 protein, will be described
elsewhere (Penrose and McBride, manuscript submit-
ted).
Immunofluorescence
Cells were plated onto glass slides 16 h before infec-
tion with PAVA viruses or induction of the metallothionein
promoter. For PAVA virus E2 expression, CV-1 cells were
infected with virus at a high multiplicity of infection and
were analyzed for E2 expression after 36–40 h. For in-
duction of wild-type E2-TA expression from CV-1 cells
stably transfected with the pMEP plasmids, cells were
induced by the addition of 1 mM CdSO4 for 4.5 h; for
induction of E2-TA1-218NLS, HA cells were induced with 1.5
mM CdSO4 for 30 h. Cells were fixed for 20 min in 4%
araformaldehyde in PBS, permeabilized with 0.1% Triton
-100 in PBS, and blocked in 0.25% gelatin, 0.25% BSA in
BS. Mouse monoclonal antibody B201 (provided by El-
iot Androphy) was added at a dilution of 1:10. Antiserum
gainst the HA epitope was obtained from Boehringer-annheim (rat monoclonal, clone 3F10; Indianapolis, IN)
nd used at a concentration of 5 mg/ml. Antiserum
against phosphorylated histone H3 was obtained from
Upstate Biotechnology (rabbit polyclonal; Lake Placid,
NY) and used at 5 mg/ml. Slides were incubated with the
primary antibodies, washed with PBS, and incubated
with either goat anti-mouse IgG (conjugated to fluores-
cein isothiocyanate or Cy5) or donkey anti-rat IgG (con-
jugated to fluorescein isothiocyanate) or donkey anti-
rabbit IgG (conjugated to Oregon green, 1:100; Jackson
Immunoresearch, West Grove, PA). Where indicated, cel-
lular DNA was stained for 5 min with Hoechst 33258 (5
mg/ml). After washes in PBS, slides were mounted in
Fluoromount G (Southern Biotechnology Associates, Bir-
mingham, AL). Where stated, 25 mg/ml propidium iodide
as added to the mounting solution. Fluorescence was
etected and photographed with Bio-Rad (Hercules, CA)
RC1024 and Leica TCS confocal laser scanning imag-
ng systems.
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